Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy

Abstract

Suboptimal LNY is independently associated with worse overall survival regardless of neoadjuvant therapy, pathological staging and patient factors in rectal cancer. This finding underlies the importance and challenge of an optimal lymph node evaluation for prognostication, especially for patients receiving neoadjuvant therapy.